Edgar Filing: Solexa, Inc.

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

HAUSER HERMANN

2. Issuer Name and Ticker or Trading Symbol
Solexa, Inc. [SLXA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

C/O SOLEXA, INC., 25861 INDUSTRIAL BLVD.

3. Date of Earliest Transaction (Month/Day/Year)
01/26/2007

(Street)

HAYWARD, CA 94545

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/26/2007		D		2,089,849	D	⁽¹⁾	0	I	By Amadeus II A LP
Common Stock	01/26/2007		D		1,393,234	D	⁽²⁾	0	I	By Amadeus II B LP
Common Stock	01/26/2007		D		975,264	D	⁽³⁾	0	I	By Amadeus II C LP
Common Stock	01/26/2007		D		46,442	D	⁽⁴⁾	0	I	By Amadeus II D GmbH and Co KG
Common Stock	01/26/2007		D		139,322	D	⁽⁵⁾	0	I	By Amadeus II Affiliates LP

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Stock Option (Right to Buy)

$ 9.06

01/26/2007

10,000

⁽⁶⁾

10/03/2016

Common Stock

10,000

$ 0

Stock Option (Right to Buy)

$ 6.2

01/26/2007

20,000

⁽⁷⁾

10/21/2015

Common Stock

20,000

$ 0

Warrant (Right to Buy)

$ 7.5

01/26/2007

60,577

⁽⁸⁾

01/19/2011

Common Stock

60,577

$ 0

By Amadeus II LP

Warrant (Right to Buy)

$ 7.5

01/26/2007

40,385

⁽⁹⁾

01/19/2011

Common Stock

40,385

$ 0

By Amadeus II B LP

Warrant (Right to Buy)

$ 7.5

01/26/2007

28,269

⁽¹⁰⁾

01/19/2011

Common Stock

28,269

$ 0

By Amadeus II C LP

Warrant (Right to Buy)

$ 7.5

01/26/2007

1,346

⁽¹¹⁾

01/19/2011

Common Stock

1,346

$ 0

By Amadeus II D GmbH and Co KG

Warrant (Right to Buy)

$ 7.5

01/26/2007

4,038

⁽¹²⁾

01/19/2011

Common Stock

4,038

$ 0

By Amadeus II Affiliates LP

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
HAUSER HERMANN C/O SOLEXA, INC. 25861 INDUSTRIAL BLVD. HAYWARD, CA 94545	X

Signatures

/s/ Hermann Hauser, by Kathy San Roman, attorney-in-fact		01/29/2007
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 718,908 shares of Illumina, Inc. common stock.
(2)	These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 479,272 shares of Illumina, Inc. common stock.
(3)	These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 335,490 shares of Illumina, Inc. common stock.
(4)	These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 15,976 shares of Illumina, Inc. common stock.
(5)	These shares were surrendered pursuant to a merger agreement between Solexa, Inc. and Illumina, Inc. in exchange for 47,926 shares of Illumina, Inc. common stock.
(6)	This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 21, 2005, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 6,880 shares at an exercise price of $18.02 per share.
(7)	This option, which provided for vesting monthly and ratably over the 12 month period beginning on October 4, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with an option to purchase 3,440 shares at an exercise price of $26.34 per share.
(8)	This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 20,838 shares at an exercise price of $21.80 per share.
(9)	This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 13,892 shares at an exercise price of $21.80 per share.
(10)	This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 9,724 shares at an exercise price of $21.80 per share.
(11)	This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 463 shares at an exercise price of $21.80 per share.
(12)	This warrant, which was exercisable 180 days from January 19, 2006, was assumed by Illumina, Inc. in connection with the merger with Solexa, Inc. and replaced with a warrant to purchase 1,389 shares at an exercise price of $21.80 per share.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.